You are here

Pfizer

FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population

Fierce Pharma

Thu, 05/22/25 - 11:27 am

prostate cancer

FDA expands warnings of heart risks on COVID shots

Axios

Wed, 05/21/25 - 10:39 pm

Moderna Therapeutics

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

BioSpace

Wed, 05/21/25 - 12:00 pm

pneumococcal disease

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

Yahoo/Reuters

Mon, 05/19/25 - 10:33 pm

non-small cell lung cancer

metastatic colorectal cancer

Pfizer-backed CellCentric secures $120M for further myeloma trials

Fierce Biotech

Mon, 05/19/25 - 11:17 am

Multiple Myeloma

clinical trials

Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm

Fierce Pharma

Sun, 05/18/25 - 10:33 pm

Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer

Fierce Pharma

Mon, 05/12/25 - 11:36 am

antibody-drug conjugates

clinical trials

In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen

Fierce Pharma

Thu, 05/8/25 - 10:56 pm

Are pharma’s DTC platforms actually creating engagement with patients?

Medical Marketing and Media

Tue, 05/6/25 - 10:27 am

patient engagement

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

CNBC

Thu, 05/1/25 - 10:58 am

drug manufacturing

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool

Wed, 04/30/25 - 11:00 am

Viking Therapeutics

Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs

BioPharma Dive

Wed, 04/30/25 - 10:58 am

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

CNBC

Tue, 04/29/25 - 08:20 am

Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial

Clinical Trials Arena

Mon, 04/28/25 - 09:39 am

clinical trials

non-muscle invasive bladder cancer

How a scrapped Pfizer drug became a winner for SpringWorks

Pharma Voice

Mon, 04/21/25 - 10:00 am

SpringWorks Therapeutics

neurofibromatosis

CDC panel backs broader use of RSV shots

BioPharma Dive

Thu, 04/17/25 - 11:25 am

Moderna Therapeutics

CDC advisers weigh lower age recommendation for RSV vaccines

Marketscreener

Wed, 04/16/25 - 11:39 am

Moderna Therapeutics

Why Pfizer Stock Topped the Market on Tuesday

Motley Fool

Tue, 04/15/25 - 07:53 pm

clinical trials

Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan

Fierce Biotech

Mon, 04/14/25 - 11:03 am

clinical trials

As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay

Fierce Pharma

Fri, 04/11/25 - 11:32 am

Pages